SCHEMBL1980448

SCHEMBL1980448

CCCCCCCCOS(=O)(=O)[O-].CCCCCCCC[n+]1ccn(C)c1

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
RECQL P46063 2/20 0.54
GLA P06280 1/20 0.54
HPGD P15428 1/20 0.54
TSHR P16473 1/20 0.54
MAPK1 P28482 1/20 0.54
EPHX2 P34913 1/20 0.54
BLM P54132 1/20 0.54
CA1 P00915 7/20 0.37
CA2 P00918 7/20 0.37
CA9 Q16790 6/20 0.37
CA12 O43570 3/20 0.37
CA7 P43166 3/20 0.37
CA14 Q9ULX7 3/20 0.37
CA3 P07451 2/20 0.37
CA4 P22748 2/20 0.37
CA6 P23280 2/20 0.37
CA5A P35218 2/20 0.37
CA5B Q9Y2D0 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4410517 1.00 RECQL (0.54) RECQLGLAHPGDTSHRMAPK1
SCHEMBL28567949 1.00 RECQL (0.54) RECQLGLAHPGDTSHRMAPK1
SCHEMBL4410563 1.00 RECQL (0.54) RECQLGLAHPGDTSHRMAPK1
SCHEMBL4409152 1.00 RECQL (0.54) RECQLGLAHPGDTSHRMAPK1
SCHEMBL4415795 1.00 RECQL (0.54) RECQLGLAHPGDTSHRMAPK1
SCHEMBL4407297 1.00 RECQL (0.54) RECQLGLAHPGDTSHRMAPK1
SCHEMBL4420327 1.00 RECQL (0.54) RECQLGLAHPGDTSHRMAPK1
SCHEMBL4419590 1.00 RECQL (0.54) RECQLGLAHPGDTSHRMAPK1
SCHEMBL20287 0.97 RECQL (0.54) RECQLGLAHPGDTSHRMAPK1
SCHEMBL4411996 0.97 RECQL (0.50) RECQLGLAHPGDTSHRMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7745520-B2 Hybrid polymer light-emitting devices THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2010-06-29 US claimed
US-7544807-B2 Alkyl sulfates such as 1-ethyl-3-methylimidazolium butyl sulfate, used as solvents or solvent adjuvants in chemical reactions, extraction agents or heat carriers in heat exchangers; low melting MERCK PATENT GMBH (DE) 2009-06-09 US claimed
US-20080084158-A1 Hybrid polymer light-emitting devices SHAO YAN 2008-04-10 US claimed
EP-1425268-B1 ORGANIC SULFATES AS IONIC LIQUIDS SOLVENT INNOVATION GMBH (DE) 2008-02-27 EP claimed
US-20080033178-A1 Alkyl sulfates such as 1-ethyl-3-methylimidazolium butyl sulfate, used as solvents or solvent adjuvants in chemical reactions, extraction agents or heat carriers in heat exchangers; low melting MERCK PATENT GMBH (DE) 2008-02-07 US claimed
US-7252791-B2 sulfonic acids and salts such as 1-ethyl-3-methylimidazolium butyl sulfate, used as solvents or solvent adjuvants in chemical reactions, extraction agents or heat carriers in heat exchangers MERCK PATENT GMBH (DE) 2007-08-07 US claimed
CN-112771019-B Catalyst system for oxidizing para-xylene and/or meta-xylene to the corresponding carboxylic acid 沙特基础工业全球技术有限公司 2023-07-07 CN disclosed
CN-112771019-A Catalyst system for oxidation of p-xylene and/or m-xylene to the corresponding carboxylic acids 沙特基础工业全球技术有限公司 2021-05-07 CN disclosed
EP-3455326-B1 COMPOSITIONS FOR ELECTROCHEMICAL CELLS MERCK PATENT GMBH (DE) 2021-02-24 EP disclosed
EP-3455326-A1 COMPOSITIONS FOR ELECTROCHEMICAL CELLS Merck Patent GmbH (DE) 2019-03-20 EP disclosed
US-10100214-B2 Ink composition for ink jet SEIKO EPSON CORPORATION (JP) 2018-10-16 US disclosed
WO-2017194435-A1 COMPOSITIONS FOR ELECTROCHEMICAL CELLS MERCK PATENT GMBH (DE) 2017-11-16 WO disclosed
US-20170283641-A1 INK COMPOSITION FOR INK JET SEIKO EPSON CORP (JP) 2017-10-05 US disclosed
EP-1587813-B1 PHOSPHONIUM AND IMIDAZOLIUM SALTS AND METHODS OF THEIR PREPARATION CYTEC CANADA INC (CA) 2007-10-03 EP disclosed
US-7252791-B2 sulfonic acids and salts such as 1-ethyl-3-methylimidazolium butyl sulfate, used as solvents or solvent adjuvants in chemical reactions, extraction agents or heat carriers in heat exchangers MERCK PATENT GMBH (DE) 2007-08-07 US disclosed
US-20070100164-A1 Arylamine processes XEROX CORPORATION (US) 2007-05-03 US disclosed
US-6942957-B2 positives; comprises polymethylmethacrylate binder; useful as lithographic printing plate precursors KODAK POLYCHROME GRAPHICS LLC (US) 2005-09-13 US disclosed
US-20050014644-A1 positives; comprises polymethylmethacrylate binder; useful as lithographic printing plate precursors EASTMAN KODAK COMPANY 2005-01-20 US disclosed
US-20040262578-A1 sulfonic acids and salts such as 1-ethyl-3-methylimidazolium butyl sulfate, used as solvents or solvent adjuvants in chemical reactions, extraction agents or heat carriers in heat exchangers MERCK PATENT GMBH (DE) 2004-12-30 US disclosed
US-20040214108-A1 Ionic liquids as dissolution inhibitors in imageable elements KODAK POLYCHROME GRAPHICS LLC 2004-10-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070100164-A1 Arylamine processes AHR, INMT, TYR RECQL 2435/4885GLA 4579/4885HPGD 3947/4885
US-20040262578-A1 sulfonic acids and salts such as 1-ethyl-3-methylimidazolium butyl sulfate, used as solvents or solvent adjuvants in chemical reactions, extraction agents or heat carriers in heat exchangers RPS4Y1, HSPA4, RPS4X RECQL 2836/4885GLA 4606/4885HPGD 3651/4885
US-20080033178-A1 Alkyl sulfates such as 1-ethyl-3-methylimidazolium butyl sulfate, used as solvents or solvent adjuvants in chemical reactions, extraction agents or heat carriers in heat exchangers; low melting MRPS34, HSPA4, SLC43A1 RECQL 2266/4885GLA 4143/4885HPGD 3931/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.